MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Martelli A et al. | Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins. | 1998 | Mutat. Res. | pmid:9804880 |
Lachnit-Fixson U and Aydinlik S | [New cycle-stabilizing contraceptive agent (Ediwal)]. | 1976 | Med Monatsschr | pmid:979900 |
Rogers A and Eastell R | Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. | 1998 | J. Bone Miner. Res. | pmid:9783546 |
Cacciatore B et al. | Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. | 1998 | Obstet Gynecol | pmid:9764629 |
Funckes CG et al. | Effect of a long-acting contraceptive drug, norethindrone enanthate, on serum zinc and copper in human volunteers. | 1976 | Contraception | pmid:975819 |
Fotherby K and Warren RJ | Bioavailability of contraceptive steroids from capsules. | 1976 | Contraception | pmid:975817 |
Sturdee DW et al. | Pregnancy associated alpha2-glycoprotein in post-menopausal women receiving hormone replacement therapy. | 1976 | Clin. Chim. Acta | pmid:975579 |
Tant D | Megaloblastic anaemia due to pyridoxine deficiency associated with prolonged ingestion of an oestrogen-containing oral contraceptive. | 1976 | Br Med J | pmid:974714 |
Gal I | Hormonal pregnancy tests and congenital malformations. | 1976 | Br Med J | pmid:974708 |
Hammar M et al. | A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. | 1998 | Br J Obstet Gynaecol | pmid:9746385 |